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Abstract Objective: To develop a
model to assess severity of illness and
predict vital status at hospital dis-
charge based on ICU admission data.
Design: Prospective multicentre,
multinational cohort study. Patients
and setting: A total of 16,784 patients
consecutively admitted to 303 inten-
sive care units from 14 October to 15
December 2002. Measurements and
results: ICU admission data (record-
ed within €1 h) were used, describ-
ing: prior chronic conditions and
diseases; circumstances related to and
physiologic derangement at ICU ad-
mission. Selection of variables for
inclusion into the model used differ-
ent complementary strategies. For
cross-validation, the model-building
procedure was run five times, using
randomly selected four fifths of the
sample as a development- and the
remaining fifth as validation-set. Lo-
gistic regression methods were then
used to reduce complexity of the
model. Final estimates of regression
coefficients were determined by use
of multilevel logistic regression.
Variables selection and weighting
were further checked by bootstraping
(at patient level and at ICU level).
Twenty variables were selected for
the final model, which exhibited good
discrimination (aROC curve 0.848),
without major differences across pa-
tient typologies. Calibration was also
satisfactory (Hosmer-Lemeshow
goodness-of-fit test H ˆ=10.56, p=0.39,
C ˆ=14.29, p=0.16). Customised equa-
tions for major areas of the world
were computed and demonstrate a
good overall goodness-of-fit. Con-
clusions: The SAPS 3 admission
score is able to predict vital status at
hospital discharge with use of data
recorded at ICU admission. Further-
more, SAPS 3 conceptually dissoci-
ates evaluation of the individual pa-
tient from evaluation of the ICU and
thus allows them to be assessed at
their respective reference levels.
Keywords Intensive care unit ·
Severity of illness · ICU mortality ·
Hospital mortality · Risk adjustment1346
Introduction
One of the crucial steps in the evaluation of risk-adjusted
outcomes is the choice of the reference database for es-
timating adequate reference lines for the analyzed vari-
ables. For the SAPS 3 to reflect the standard of practices
and outcome in intensive care at the beginning of the 21st
century, we decided to collect data from a large sample of
intensive care units (ICUs) worldwide. Other models have
restricted data collection to large ICUs in Europe or North
America—SAPS II [1], MPM II [2], APACHE II [3] and
APACHE III [4], a strategy that minimizes the hetero-
geneity of the sample but restricts the generalization of
the results.
At the statistical level, there is also a need for change,
in order to take into account the hierarchic nature of our
data [5, 6]. Current general outcome prediction models do
not consider the existence of clinical and nonclinical
factors, aggregated at the ICU level, that can have an
important impact on prognosis. Instead, they assume that
these factors are either not important or are randomly
distributed throughout large samples and that the variation
between ICUs is small. This assumption is not likely to be
borne out at the ICU level for either nonclinical factors
(e.g. organization and management, organizational cul-
ture) or clinical factors (e.g. clinical management, diag-
nostic and therapeutic strategies). If the variation between
ICUs is not negligible, it will compromise the stability of
the equations used to compute predicted mortality. Fur-
thermore, the published models consider the relation be-
tween performance and severity of illness to be constant,
and that may not be the case, since performance can vary
within ICUs according to the severity of illness of the
patients [7, 8]. To overcome this problem, we chose to
adopt a new strategy for the development of the SAPS 3
score and to apply statistical modelling techniques that
control for the clustering of patients within ICUs instead
of assuming the independence of observations. Concep-
tually, the SAPS 3 admission score comprises the fol-
lowing parts:
First, the SAPS 3 ADMISSION SCORE, represented by
the arithmetic sum of three subscores, or boxes:
– Box I: What we know about the patient characteristics
before ICU admission: age, previous health status, co-
morbidities, location before ICU admission, length of
stay in the hospital before ICU admission, and use of
major therapeutic options before ICU admission.
– Box II: What we know about the circumstances of
ICU admission: reason(s) for ICU admission, anatomic
site of surgery (if applicable), planned or unplanned
ICU admission, surgical status and infection at ICU
admission.
– Box III: What we know about the presence and degree
of physiologic derangement at ICU admission (within
1 h before or after admission).
Second, the SAPS 3 PROBABILITY OF DEATH during
a certain period of time (in the case of the main model, the
probability of death at hospital discharge).
Given our objective of evaluating not only individual
patient outcome but also the effectiveness of ICU prac-
tices, we focused the model on data available at ICU
admission or shortly thereafter. This model will be
completely open and available free of any direct or in-
direct charges to the scientific community.
Methods and statistical analysis
Primary variable selection
Based on the SAPS 3 Hospital Outcome Cohort as de-
scribed in Part 1 of this report, continuous predictive
variables were categorized in mutually exclusive cate-
gories based on smoothed curves such as LOWESS [9],
showing the univariate dependence of hospital mortality
on the predictive variables. Classes of categorical vari-
ables were also collapsed according to their univariate
hospital mortality levels using multidimensional tables
and clinical judgment as appropriate, depending on the
nature of the data. Additively, regression trees (MART)
[10] were applied to check the cutoffs.
Missing values were coded as the reference or “nor-
mal” category for each variable. When dual data collec-
tion was used—maximum and minimum values recorded
during a certain time period—missing maximum values
of a variable were replaced by the minimum, if docu-
mented, and vice versa. Some regression imputations
were performed if noticeable correlations to available
values could be exploited. For a detailed description of
data collection and handling, see Part 1 of this report.
Selection of variables was done according to their
association with hospital mortality, together with expert
knowledge and definitions used in other severity of illness
scoring systems. The objective of using this combination
of techniques rather than regression-based criteria alone
was to reach a compromise between over-sophistication
of the model and knowledge from sources beyond the
sample with its specific case mix and ICU characteristics.
Cross validation
For being able to cross-validate the model, we randomly
extracted five roughly equal-sized parts based on number
of patients from the database, as suggested previously
[11]. In a second approach, partitioning was based on
ICUs and not on patients. It was thus possible to run the
model-building procedure five times in each of the two
approaches, each time taking four parts of the sample as a
development set and the remaining one as the validation
set. This allowed to estimate the variability of prediction1347
resulting from the construction process of the prognostic
score. A further check of the stability of the predictions
was made by partitioning the sample according to major
patient characteristics, such as surgical status and infec-
tion status.
The quality of predictions in the validation sets was
assessed by looking at the goodness-of-fit in terms of the
p values for the Hosmer-Lemeshow tests C ˆ and H ˆ [13]
and the discriminative capability of the models by the use
of the area under the receiver operating characteristic
(aROC) curve [14, 15]. Another criterion to judge the
appropriateness of the model was the fit in certain sub-
samples, defined according to major patient typologies
[16].
Reducing model complexity
To reduce the complexity of the model classes, we con-
centrated on logistic regression. In the first step a stepwise
logistic regression was used to identify the significant
predictors in each of the five subsamples. A threshold of
0.01 for the p value was generally applied for inclusion in
the model to separate irrelevant predictors [12]. At this
stage we also evaluated if interactions among these pre-
dictors would influence results. Interactions, however, did
not make a valuable contribution for the prediction.
Significant predictors (n=70) were in a second step
entered into a logistic regression model. The criterion for
a predictor to enter the model was homogeneity across the
five model-building processes: in principle, predictors
should enter the model in all five development sets, but
depending on the frequency of the predictor in the sam-
ples, the magnitude of the effect, and medical reasoning,
some predictors were included if they appeared in the
model in at least three subsamples. An example is the
presence of Acquired Immunodeficiency Syndrome
(AIDS): it was selected as a comorbidity in only 81 pa-
tients (0.48%), but the mortality—without controlling for
other variables—in these patients was 42%. By taking all
the above steps to identify the set of predictors, although
deliberately not using any formal numeric criterion, we
reduced the complexity of the model to minimize the
amount of overfitting: This process resulted in 61 item
classes (representing 20 variables) remaining in the final
model.
Using the parameter estimates from the logistic re-
gression as starting values, a multilevel model was ap-
plied in the next step, using patient characteristics as fixed
effects and ICUs as a random effect. Estimates were again
calculated for the five development sets (for both, patient
and ICU -based development subsamples).
At this stage it was checked if rounding of coefficients
(which allows for an easier manual computation of the
score) would influence results, which was found not to be
the case. Consequently, this was the approach chosen for
the final construction of the SAPS 3 admission score
sheet.
The stability of the processes of variable selection and
reducing complexity was further checked by bootstraping
with replacement the total sample 100 times, both at pa-
tient level and at ICU level.
Predicting hospital mortality
After this step was completed, a shrinking power trans-
formation was applied. This procedure uses log-transfor-
mation of the score to reduce the influence of extreme
score values (outliers) on the mortality prediction. For this
purpose, the SAPS 3 score and the transformed log
(SAPS 3 + g) score were used to predict hospital mor-
tality. Conventional logistic regression was used in the
evaluation of this step because of convergence problems
for the corresponding multilevel model in a few sub-
samples. The best shrinkage model then was selected
(excluding the trivial model with the SAPS 3 score as the
single predictor) by checking which of the terms in the
model contributed best to the prediction and was more-
over stable over the respective validation sets and specific
subsamples. This procedure was applied on both, patient
and ICU -based subsamples.
After finishing these steps of cross-validation, the final
estimates for the selected predictors of the SAPS 3 score
as well as the selected shrinkage procedure were then
calculated from the total sample of patients.
To arrive at the customised models for each major
geographic region, specific customised equations were
calculated, relating, by logistic regression, the trans-
formed log (SAPS 3 + g) admission scores computed as
described above to the vital status at hospital discharge.
This process allows both the intercept and the slope of the
curve relating the SAPS 3 admission score to change
across different regions. The goodness-of-fit of these
equations was evaluated by means of the same metho-
dology used for the global sample.
SAS for Windows, version 8.02 (SAS Institute Inc.,
Cary, NC, USA) and MLwiN version 1.10.0007 (Centre
for Multilevel Modelling, Institute of Education, London,
UK) and the R Software Package (http://www.r-pro-
ject.org) were used for the development of the model.
Results
Based on the methodology described, 20 variables were
selected for the SAPS 3 admission score (Tables 1 and 2):
– Five variables for evaluating Box I: age, co-morbidi-
ties, use of vasoactive drugs before ICU admission,
intrahospital location before ICU admission, and
length of stay in the hospital before ICU admission;1348
– Five variables for evaluating Box II: reason(s) for ICU
admission, planned/unplanned ICU admission, surgical
status at ICU admission, anatomical site of surgery,
and presence of infection at ICU admission and place
acquired;
– Ten variables for evaluating Box III: lowest estimated
Glasgow coma scale, highest heart rate, lowest systolic
blood pressure, highest bilirubine, highest body tem-
perature, highest creatinine, highest leukocytes, lowest
platelets, lowest hydrogen ion concentration (pH), and
ventilatory support and oxygenation.
An estimation of the variability of the coefficients in the
overall sample and in the five disjoint subsamples is given
in Table E8 of the Electronic Supplementary Material
(ESM), together with their respective coefficients (un-
rounded and rounded) and p values. The SAPS 3 admis-
sion score can thus, in theory, vary from a minimum of 0
points to a maximum of 217 points. The distribution of
the SAPS 3 admission score in our sample is presented in
Fig. 1. The minimum value observed was 5, and the
maximum value was 124, with a mean of 49.9€16.6
(mean € SD) and a median of 48 (38–60). The highest
explanatory power came from Box I, with Box II and Box
III being less important for the outcome; the three boxes
represent 50%, 22.5% and 27.5%, respectively, of the
total Nagelkerke’s R-Square. The relationship between
the SAPS 3 and vital status at hospital discharge is given
by the equation:
Logit =  32.6659 +ln(SAPS 3 score +20.5958)  7.3068
and the probability of mortality by the equation:
Probability of death = e
logit/(1+e
logit).
The relationship between the SAPS 3 admission score and
the respective probability of death in the hospital is de-
scribed in Fig. 2. Overall, no combined discrepancy be-
tween observed and expected outcomes across all of the
strata was outside sampling variability as demonstrated
a Hosmer-Lemeshow goodness-of-fit test H ˆ of 10.56
(p=0.39) and a Hosmer-Lemeshow goodness-of-fit test C ˆ
of 14.29 (p=0.16) (Figs. 3, 4 and Table E9, ESM). The
overall discriminatory capability of the model, as mea-
sured by aROC curve, was 0.848. The goodness-of-fit
according to major patient typologies (surgical status,
trauma, and infection) can be found in Table 3. Calibra-
tion and discrimination presented differences across dif-
ferent geographic areas: the best predictive results were
achieved in patients from Northern Europe (observed-to-
expected [O/E] mortality ratio 0.96 [0.83–1.09]) and the
worst predictive results were obtained in patients from
Central and South America (O/E mortality ratio, 1.30
[1.23–1.37]); see also Table 4 and Fig. 5 and Appendix B
in the ESM.
For a more precise estimation of the probability of
death in the hospital across the different geographic re-
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gions, specific customised equations were calculated
(Table 5). This customised approach allows each ICU to
choose its own reference line for the prediction of hospital
mortality: either the overall SAPS 3 hospital mortality
sample or its own regional subsample. This approach can
be supplemented in the future by customised equations at
the country level if data are available and if a more pre-
cise estimation of outcome in a specific setting is needed.
The overall goodness-of-fit of these customised equations
for each region is presented in Table 5. A complete list of
the number of patients and the respective O/E mortality
ratios by country, according to the global equation and the
regional equations, are presented in Tables E10 and E11
of the ESM, with point estimates varying at the global
level from 0.68 (0.56–0.80) to 2.05 (1.27–2.82). Most O/E
ratios are close to the identity line, as expected for a stable
model.
Discussion
We have presented the results of a large multicentric,
multinational study aimed at updating the SAPS II model.
This study was necessary for several reasons. First, the
reference line used by SAPS II was derived from a da-
tabase collected in the early 1990s; since that time, there
have been changes in the prevalence of major diseases
and in the availability and use of major diagnostic and
therapeutic methods that are associated with a shift to-
ward poor calibration of older models such as SAPS II
and APACHE III [17, 18]. Second, SAPS II was devel-
oped from a database built exclusively from patients in
Europe and North America. This sample may not be
representative of the case mix and medical practices that
constitute the reality of intensive care medicine in the rest
of the world (e.g. Australasia or South America), where
variability in structures and organization is probably re-
lated to outcome [19].
Third, since computation of predicted mortality is
based on a reference database, the user should be able to
choose between them, i.e., a global database, which pro-
vides a broader comparison at the potential cost of less
relevance to local conditions, and a regional database,
which provides a better comparison with ICUs in geo-
Table 2 SAPS 3 admission scoresheet – Part 2
Box II – continued
ICU admission
12) 16
Reason(s) for ICU admission
Cardiovascular: Rhythm disturbances
13) –5
Neurologic: Seizures
13) –4
Cardiovascular: Hypovolemic hemorrhagic shock,
Hypovolemic non hemorrhagic shock. / Digestive:
Acute abdomen, Other
3)
3
Neurologic: Coma, Stupor, Obtuned patient,
Vigilance disturbances, Confusion, Agitation, Delirium
4
Cardiovascular: Septic shock. / Cardiovascular:
Anaphylactic shock, mixed and undefined shock
5
Hepatic: Liver failure 6
Neurologic: Focal neurologic deficit 7
Digestive: Severe pancreatitis 9
Neurologic: Intracranial mass effect 10
All others 0
Anatomical site of surgery
Transplantation surgery: Liver, Kidney, Pancreas,
Kidney and pancreas, Transplantation other
–11
Trauma – Other, isolated:
(includes Thorax, Abdomen, limb); Trauma – Multiple
–8
Cardiac surgery: CABG without valvular repair –6
Neurosurgery: Cerebrovascular accident 5
All others 0
12) Every patient gets an offset of 16 points for being admitted (to
avoid negative SAPS 3 Scores).
13) If both reasons for admission are present, only the worse value
(–4) is scored.
Fig. 1 Distribution of the
SAPS 3 admission score in the
SAPS 3 database1351
graphic proximity but at the cost of losing comparability
with ICUs in other parts of the world. A third possibility
could be added—a country-representative database—but
such a database would raise the problem of whether the
ICUs selected were representative of a certain country.
Fourth, the development of computers in recent years
has created easy access to strong computational power.
One of the implications of this is that it is now possible to
develop a new outcome prediction model, based on digital
data acquisition and analysis, with minimal differences in
definitions and application criteria. These advances were
coupled with extensive automatic logical and error-
checking capabilities and the availability of data collec-
tion manuals online. Moreover, developers of the SAPS 3
model could take advantage of computer-intensive
methods of data selection and analysis, such as the use of
additive partition trees and logistic regression with ran-
dom effects. Several new statistical techniques have been
used in recent years to allow a more stable prediction of
outcome, such as genetic algorithms and artificial neural
Fig. 2 Relationship between
the SAPS 3 admission score and
the respective probabilities of
hospital mortality
Fig. 3 Hosmer-Lemeshow
goodness-of-fit test C ˆ in the
overall sample. Predicted risk of
hospital death, observed hospi-
tal mortality rate, and the cor-
responding number of patients
per decile are shown. Columns:
Number of patients; squares:
mean SAPS 3-predicted mor-
tality per decile; circles: mean
observed mortality per decile1352
Fig. 4 Hosmer-Lemeshow
goodness-of-fit test H ˆ in the
overall sample. Predicted risk of
hospital death, observed hospi-
tal mortaliy rate, and the corre-
sponding number of patients per
decile are shown. Columns:
Number of patients; squares:
mean SAPS 3-predicted mor-
tality per decile; circles: mean
observed mortality per decile
Table 3 Performance of the
model across major patient
typologies
Patient characteristics GOF
test H ˆ
p GOF
test C ˆ
p O/E
ratio
95% CI aROC
Trauma patients 19.92 0.03 9.03 0.53 1.03 0.93–1.12 0.854
Non-operative
admissions
a 14.86 0.14 17.8 0.06 1.01 0.98–1.04 0.825
Scheduled surgery
a 11.5 0.32 27.39 <0.01 0.97 0.90–1.03 0.825
Emergency surgery
a 4.97 0.89 12.88 0.23 1.00 0.95–1.05 0.809
No infection
b 8.57 0.57 14.77 0.14 1.00 0.97–1.02 0.846
Community-acquired
infection
c 8.4 0.59 11.76 0.3 1.00 0.96–1.05 0.786
Hospital-acquired
infection
d 15.21 0.12 7.11 0.72 1.02 0.97–1.07 0.77
GOF: Hosmer-Lemeshow goodness-of-fit; O/E: observed-to-expected mortality; CI: 95% confidence
interval; aROC: area under receiver operating characteristic (curve)
a Non-operative admissions, scheduled surgery emergency surgery: see data definitions appendix C,
ESM
b No infection: Patients not infected at ICU admission
c Community-acquired infection: Patients with community-acquired infection at ICU admission
d Hospital-acquired infection: Patients with hospital-acquired infection at ICU admission
Table 4 Performance of the
model in the global sample and
in different geographic areas
Regions GOF
test H ˆ
p GOF
test C ˆ
p O/E
ratio
95% CI aROC
Australasia 15.25 0.12 8.09 0.62 0.92 0.85–0.99 0.839
Central,
South America
78.01 <0.01 80.82 <0.01 1.30 1.23–1.37 0.855
Central,
Western Europe
56.45 <0.01 47.89 <0.01 0.84 0.79–0.90 0.861
Eastern Europe 19.45 0.03 18.69 0.04 1.09 1.00–1.19 0.903
North Europe 2.44 0.99 2.34 0.99 0.96 0.83–1.09 0.814
Southern Europe,
Mediterranean
countries
14.18 0.16 20.78 0.02 1.02 0.98–1.05 0.834
North America 10.57 0.39 9.63 0.47 0.91 0.78–1.04 0.812
Global database 10.56 0.39 14.29 0.16 1 0.98–1.02 0.848
GOF: Hosmer-Lemeshow goodness-of-fit; O/E: observed-to-expected mortality; CI: 95% confidence
interval; aROC: area under the receiver operating characteristic (curve).1353
networks [20, 21], dynamic microsimulation techniques
[22], and first- and second-level customization strategies
[23–25]. However, the value of these techniques is for the
moment limited, usually because they are based on re-
gional databases [24–26] that prevent extrapolation to
other settings; moreover, their superiority in even the
regional setting still needs to be established.
Finally, the SAPS 3 conceptually dissociates evalua-
tion of the individual patient from evaluation of the ICU.
Thus, for individual patient assessment, the system sep-
arates the relative contributions to prognosis of (i) chronic
health status and previous therapy, (ii) the circumstances
related to ICU admission, and (iii) the presence and de-
gree of physiologic dysfunction. It is interesting to note
that one half of the predictive power of the model is
achieved with Box I, i.e., with the information that is
available before ICU admission. The prognostic capabil-
ities of the model can be further improved by 22.5% by
using data related to the circumstances of the ICU ad-
mission (Box II), and by another 27.5% by the incorpo-
ration of physiologic data (Box III). These numbers are
different from those published by Knaus et al. [4] but are
based on what we have learned in the last years about
prognostic determinants in the critically ill patient.
For performance evaluation, several reference lines
should be used, with risk-adjusted mortality in different
Fig. 5 Observed-to-expected
(O/E) mortality ratios by region.
Observed-to-expected (O/E)
mortality ratios are shown by
region. Bars indicate 95% con-
fidence intervals
Table 5 Customized SAPS 3 admission equations for the different geographic areas
Area Equation GOF H ˆ p GOF C ˆ p O/E CI
Australasia Logit= 22.5717 + ln (SAPS 3 score + 1)
 5.3163
10.43 0.40 2.20 0.99 1.00 0.93–1.07
Central, South America Logit= 64.5990 + ln (SAPS 3 score + 71.0599)
 13.2322
8.94 0.54 7.03 0.72 1.00 0.94–1.06
Central, Western Europe Logit= 36.0877 + ln (SAPS 3 score + 22.2655)
 7.9867
15.13 0.13 12.15 0.27 1.00 0.94–1.06
Eastern Europe Logit= 60.1771 + ln (SAPS 3 score + 51.4043)
 12.6847
10.13 0.43 7.12 0.71 1.00 0.92–1.08
North Europe Logit= 26.9065 + ln (SAPS 3 score + 5.5077)
 6.2746
3.45 0.97 2.22 0.99 1.00 0.86–1.14
Southern Europe,
Mediterranean countries
Logit= 23.8501 + ln (SAPS 3 score + 5.5708)
 5.5709
5.28 0.87 13.12 0.22 1.00 0.97–1.03
North America Logit= 18.8839 + ln (SAPS 3 score + 1)
 4.3979
4.22 0.93 4.47 0.92 1.00 0.86–1.14
GOF H ˆ: Hosmer-Lemeshow goodness-of-fit H ˆ test; GOF C ˆ: Hosmer-Lemeshow goodness-of-fit C ˆ test; p: respective p-values; O/E:
observed-to-expected mortality ratio; CI: 95% confidence interval1354
patient typologies and not only O/E mortality ratios at
hospital discharge in the overall ICU population [27]. The
results of the SAPS 3 study showing that different O/E
ratios were observed in different regions of the world
should be explored further, since, apart from regional
differences in case mix (not taken into account by the
model), they can also be related to regional variations in
structures and organization of acute medical care, to
different lifestyles (e.g., prevalence of obesity, or alcohol
and tobacco use) and/or—though less likely—to genetic
differences among populations.
We would like to re-emphasize that the model pre-
sented here is based exclusively on data (including
physiologic data) available within 1 h of ICU admission
and calibrated for manual data acquisition; consequently,
it should be expected to overestimate mortality when an
automatic patient data management system with a high
sampling rate is used [28, 29]. Limiting acquisition of
physiologic data to the hour of ICU admission should
minimise the impact of this factor when compared with
models based on the most deranged data from the first
24 h after ICU admission, probably at the expense of a
small decrease in the ROC curve, a greater sensitivity to
the exact time point at which admission to ICU occurs,
and therefore more reliant on the assumption that mea-
sured physiology alone (as opposed to changes in physi-
ology) predict outcome. It also allows the prediction of
mortality to be done before ICU interventions take place.
This gives the SAPS 3 admission model a major advan-
tage over existing systems, such as the SAPS II or the
APACHE II and III, since all these systems can be af-
fected by the so-called Boyd and Grounds effect: the
occurrence of more abnormal physiologic values during
the first 24 h in the ICU, leading to an increase in com-
puted severity of illness and a corresponding increase in
predicted mortality. These increases may, however, be
due not to a greater intrinsic severity of illness of the
patient but to the provision of suboptimal care in the first
24 h of ICU admission, when a stable patient may be
allowed to deteriorate [30].
Further studies should be done of factors occurring
after ICU admission that influence risk-adjusted mortali-
ty. We should keep however in mind that this approach
comes with one potential pitfall: a possible decrease in the
amount of data available for the computation of the
model; also, the shorter time period for data collection
can eventually increase the likelihood of missing physi-
ological data and the reliance on the assumption that
missing physiological data are normal. This effect should
be small, considering the widespread availability of
monitoring and point-of-case analysers.
Having demonstrated the internal validity of the
SAPS 3 admission model by the extensive use of cross-
validation techniques, we should stress that external val-
idation is also necessary. The fact that the overall data-
base was not collected to be representative of the global
case-mix (and especially the case-mix of specific regional
areas or patient typologies such as specific diseases)
should be empirically tested. Furthermore, the rate of
deterioration of our estimates over time should be fol-
lowed by the appropriate use of temporal validation, es-
pecially to avoid what Popovich called grade inflation
[18].
The SAPS 3 system was developed to be used free of
charge by the scientific community; no proprietary in-
formation regarding the scientific content is retained. All
the coefficients needed for the computation of outcome
probabilities are available in the published material. The
SAPS 3 can even be computed manually, using a simple
scoresheet, although it was designed to be integrated into
computerised data acquisition and storage systems that
allow the automatic check of the quality of the registered
data.
In conclusion, we can say that at the end of this stage
of the project, we have been able to overcome some of the
problems inherent in current risk-adjustment systems. We
have minimized user-dependent problems through the
publication of careful, detailed definitions and criteria for
data collection [31]. We have also addressed the patient-
dependent problems by expanding the reference database
and making it more representative of reality, in order to
include the maximum possible range of variations for
patient-centred variables and resulting patient-centred
outcomes. This approach was complemented by the de-
velopment of specific customised equations for major
areas of the world, allowing ICUs to choose a reference
line for outcome prediction—the global database or the
regional database for their own area.
Users of these models should keep in mind that
benchmarking is a process of comparing an ICU with a
reference population. The appropriate choice of reference
population is difficult, and we cannot simply change it
because the observed-to-predicted mortality rate is not the
one we want. For this reason, the choice should depend on
the objective of the benchmark: more precise estimation
will need local or regional equations, developed from a
more homogeneous case mix. A generalisable estimation
will, on the other hand, need more global equations de-
veloped from a more representative case mix.
Last but not least, we have successfully addressed
some of the problems of prognostic model development,
especially those related to the underlying statistical as-
sumptions for the use of specific methods for selection
and weighting of variables and the conceptual develop-
ment of outcome prediction models. In the future, multi-
level modelling with varying slopes (and not just random
intercepts) might be able to give a better answer to re-
searchers but for the moment they would make the
models to complex to be managed outside a research
environment.1355
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